APNewsBreak: FDA to review inhalable caffeine
February 19, 2012 By RODRIQUE NGOWI , Associated Press in Health
In this Monday, Jan. 23, 2012 still file photo taken from video, students try free samples of AeroShot, an inhalable caffeine packed in a lipstick-sized canister, on the campus of Northeastern University in Boston. The Food and Drug Administration will investigate the safety and legality of the product created by Harvard biomedical engineering professor David Edwards. (AP Photo/Rodrique Ngowi, File)
(AP) -- U.S. Food and Drug Administration officials plan to investigate whether inhalable caffeine sold in lipstick-sized canisters is safe for consumers and if its manufacturer was right to brand it as a dietary supplement.
AeroShot went on the market late last month in Massachusetts and New York, and it's also available in France. Consumers put one end of the canister in their mouths and breathe in, releasing a fine powder that dissolves almost instantly.
Each grey-and-yellow plastic canister contains B vitamins, plus 100 milligrams of caffeine powder, about the equivalent of the caffeine in a large cup of coffee.
AeroShot inventor, Harvard biomedical engineering professor David Edwards, says the product is safe and doesn't contain taurine and other common additives used to enhance the caffeine effect in energy drinks.
AeroShot didn't require FDA review before hitting the U.S. market because it's sold as a dietary supplement. But New York's U.S. Sen. Charles Schumer said he met with FDA Commissioner Dr. Margaret Hamburg and she agreed to review the safety and legality of AeroShot.
"I am worried about how a product like this impacts kids and teens, who are particularly vulnerable to overusing a product that allows one to take hit after hit after hit, in rapid succession," Schumer said.
The senator on Sunday planned to announce the AeroShot review.
Meanwhile, an FDA official who was at the meeting confirmed the decision, telling The Associated Press that the review will include a study of the law to determine whether AeroShot qualifies as a dietary supplement. The product will also be tested to figure out whether it's safe for consumption, the official said.
The official spoke on the condition of anonymity because that official was not authorized to discuss the matter.
Schumer pressed the FDA in December to review AeroShot, saying he fears that it will be used as a club drug so that young people can keep going until they drop. He cited incidents that occurred last year when students looking for a quick and cheap buzz began consuming caffeine-packed alcoholic drinks they dubbed "blackout in a can" because of their potency.
Pressure from the senator and others helped persuade the FDA to stop the marketing, distribution and sale of these beverages, including Four Loko.
"We need to make sure that AeroShot does not become the next Four Loko by facilitating dangerous levels of drinking among teenagers and college students," Schumer said in a statement.
Breathable Foods Inc., which makes AeroShot in France, says the product is different from the potent beverages. The company says that it's not targeting anyone under 18 and that AeroShot safely delivers caffeine into the mouth, just like coffee does.
A single unit costs $2.99 at convenience stores, mom-and-pops, and liquor and online stores. The product packaging warns people not to consume more than three AeroShots a day.
"When used in accordance with its label, AeroShot provides a safe shot of caffeine and B vitamins for ingestion," the manufacturer says on its website. "Caffeine has been proven to offer a variety of potential benefits for health to individuals when consumed in moderation, from providing energy to enhancing attention and focus."
AeroShot, the flagship product of Cambridge, Mass.-based Breathable Foods, is the product of a conversation that Edwards had with celebrity French chef Thierry Marks over lunch in the summer of 2007.
The first venture Edwards worked on with Harvard students was the breathable chocolate, called Le Whif. Now he's preparing to promote a product called Le Whaf, which involves putting food and drinks in futuristic-looking glass bowls and turning them into low calorie clouds of flavor.
©2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
Getting caffeine fix as easy as taking deep breath
Feb 08, 2012 |
not rated yet |
0
-
US watchdog says caffeinated alcoholic drinks unsafe
Nov 17, 2010 |
not rated yet |
0
-
Caffeine powder is recalled
May 21, 2007 |
not rated yet |
0
-
Stimulant-enhanced beverages add new danger to alcohol consumption
Nov 05, 2010 |
not rated yet |
0
-
Sodas and energy drinks can supply a surprising caffeine jolt
Mar 14, 2006 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Systematic screening of med adherence will ID barriers
(HealthDay)—Implementation of systematic monitoring for medication adherence will allow for identification of barriers to adherence and tailoring of interventions, according to a viewpoint piece published ...
Health
1 hour ago |
not rated yet |
0
More doctors, hospitals using electronic records
(AP)—The Obama administration says more doctors and hospitals are embracing technology as adoption of computerized medical records reaches a "tipping point" in America.
Health
2 hours ago |
not rated yet |
0
Hospitals profit when patients develop bloodstream infections
Johns Hopkins researchers report that hospitals may be reaping enormous income for patients whose hospital stays are complicated by preventable bloodstream infections contracted in their intensive care units.
Health
3 hours ago |
not rated yet |
0
Alleviating hunger in the US, it's a SNAP, researcher says
A University of Illinois researcher says that the cornerstone of our efforts to alleviate food insecurity should be to encourage more people to participate in the Supplemental Nutrition Assistance Program (SNAP) "because ...
Health
3 hours ago |
not rated yet |
0
Parent and teacher support protects teens from sleep problems and depression
A new study suggests that disturbed sleep in adolescents is associated with more symptoms of depression and greater uncertainly about future success. However, perceived support and acceptance from parents and teachers appears ...
Health
5 hours ago |
not rated yet |
0
Fecal microbiota tx feasible for recurrent C. difficile in HIV
(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Intern ...
FDA panel backs experimental Merck insomnia drug
(AP)—A federal panel of medical experts says that an experimental insomnia drug from Merck & Co Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty ...
Having both migraines, depression may mean smaller brain
(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
Slowing the aging process—only with antibiotics
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
Novel approach for influenza vaccination shows promise in early animal testing
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...
Feb 22, 2012
Rank: not rated yet